Previous 10 | Next 10 |
2023-09-04 09:30:00 ET After its stock fell 31% on Aug. 28, leaving it down by 72% in the last 12 months, NovoCure (NASDAQ: NVCR) shareholders are bound to be quite displeased. The cancer-treating device maker remains unprofitable despite having its Optune portable therapy machine a...
2023-08-31 18:52:06 ET Shares of Novocure (NASDAQ: NVCR) are down 25.9% so far this week as of the market close on Thursday, according to data provided by S&P Global Market Intelligence , as the company announced a discouraging update on the phase 3 INNOVATE-3 clinical trial...
2023-08-31 09:55:00 ET On Monday, shares of healthcare company NovoCure (NASDAQ: NVCR) nosedived by a staggering 38%. That was because the company's ovarian cancer treatment failed to demonstrate that it could improve patient survival rates. As a result of the decline, the stock hit...
Novocure (NASDAQ: NVCR) announced today that data from the randomized phase 3 LUNAR clinical trial evaluating the use of Tumor Treating Fields (TTFields) therapy together with standard systemic therapies for the treatment of metastatic non-small cell lung cancer (NSCLC) following progression on o...
2023-08-29 16:27:46 ET More on NovoCure NovoCure: TTFields' Ovarian Trial Short-Circuits (Rating Downgrade) NovoCure Limited: Record Losses, Falling Margins, And Downward Momentum NovoCure: Uncertain Regulatory Path And Slowing Growth NovoCure Limited ( N...
2023-08-29 05:44:30 ET Summary NovoCure's Tumor Treating Fields technology faces clinical doubt following a failed phase 3 ovarian cancer trial. Despite a strong liquidity position and manageable debt, NVCR lags the S&P 500 by 70%, indicating potential growth challenges. G...
2023-08-28 13:25:50 ET Gainers: Mobile Infrastructure Corp ( OTC:MBIC ) +88% . Hersha Hospitality Trust ( HT ) +56% . GD Culture Group Limited ( GDC ) +45% . Genius Group Limited ( GNS ) +44% . Hawaiian Electric Industries ( HE ) +...
2023-08-28 10:05:32 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half XLV Vs. VHT: A Head-To-Head Healthcare ETF C...
2023-08-28 08:16:32 ET More on pre-market losers: AMC Crash Limits Turnaround Potential AMC: Bankruptcy Is Almost Certain Stocks To Watch: Spotlight On Nvidia, AMC Entertainment, Snowflake, Twilio And DICK'S Sporting Goods AMC Entertainment's APE Conversion: ...
2023-08-28 07:54:18 ET More on NovoCure NovoCure Limited: Record Losses, Falling Margins, And Downward Momentum NovoCure: Uncertain Regulatory Path And Slowing Growth NovoCure Limited ( NVCR ) Q2 2023 Earnings Call Transcript NovoCure Limited 2023 Q2 - Re...
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-25 17:30:15 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q2 2024 Earnings Call Jul 25, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q2 2024 Earnings Call Transcript
Quarterly net revenues of $150 million, up 19% year-over-year, with 3,963 active patients on therapy as of June 30, 2024 Positive results from Phase 3 METIS trial in brain metastases from non-small cell lung cancer presented at ASCO 2024 Novocure (NASDAQ: NVCR) today reported fi...